Overview

A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the efficacy, and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy
Phase:
PHASE2
Details
Lead Sponsor:
Shandong Suncadia Medicine Co., Ltd.